Science & Technology
Targeting retinoid acid metabolic pathways to treat noise-induced hearing loss
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41DC021394-01
Award Ceiling
$291K
Award Floor
$291K
Close Date
May 31, 2025
Total Funding
$291K
Expected Awards
1
Posted Date
Jun 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41DC021394-01
Description
STTR Phase Phase I award: "Targeting retinoid acid metabolic pathways to treat noise-induced hearing loss" awarded to DERMAXON LLC in MISSOULA, Montana. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $290,920. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.